Diabetes
Video
CAC scores in type 1 diabetes no higher than general population
CHICAGO – Most type 1 diabetes patients have a coronary artery calcium score of zero.
Conference Coverage
Empagliflozin reduces left ventricular mass
CHICAGO – New finding helps explain mechanism underlying the SGLT2 inhibitor’s cardiovascular benefits.
From the Journals
Children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes and cardiovascular disease
Risk for type 2 diabetes mellitus and cardiovascular disease in adulthood can be calculated by measuring cardiorespiratory fitness in childhood....
Conference Coverage
Cardiologist: Obesity has basically stopped progress on cardiovascular disease
NASHVILLE – “We share these patients; let’s work together on trying to make them better,” said Steven Nissen, MD.
Conference Coverage
DECLARE: Dapagliflozin improves some cardiovascular, renal outcomes
The large outcomes trial didn’t show a benefit in major adverse cardiovascular events.
From the Journals
Lower glucose targets show improved mortality in cardiac patients
Lower blood glucose targets in critically ill cardiac patients are associated with lower 30-day mortality, compared with higher targets.
Conference Coverage
Closed-loop basal insulin delivery improves suboptimal T1DM control
BERLIN – Across a wide age range, closed-loop insulin delivery improved glycemic control and reduced hypoglycemia risk versus sensor-augmented...
Conference Coverage
DPP-4 drugs for diabetes may protect kidneys too
Mortality declined dramatically in patients with type 2 diabetes mellitus who took the medication over an average of 3 years.
Feature
Dulaglutide meets primary endpoint in REWIND
.
Conference Coverage
Sleep: The new frontier in cardiovascular prevention
MUNICH - Sleep that’s too little, too much, or too disrupted boosts cardiovascular risk.
News
Canagliflozin approved for cardiovascular event risk reduction
.